Skip to content

GAP ENDO-EXO MEDULLARY SYSTEM GAP-N56-28Recalls & reported problems

Orthopediatrics Canada ULC · Nail Ø5.6mm X 280mm · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07540194000866), received between Jul 23, 2021 and Jul 23, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Fracture” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Fracture1

Patient problems

  • Bone Fracture(s)1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 23, 2021Fracture; Fracture

    ON (B)(6) 2021, THE GAP ENDO-EXO MEDULLARY SYSTEM NAIL GAP-56-28 WAS IMPLANTED IN THE TIBIA OF A PATIENT WITH CONGENITAL TIBIAL PSEUDOARTHROSIS. THE NAIL WAS REPORTED BROKEN ON (B)(6) 2021, 10 WEEKS AND FOUR DAYS AFTER IMPLANTATION.

    Patient problems: Bone Fracture(s)

    MAUDE report 12218708 ↗

Other ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES devices

All ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page